ReviewCancers2021

Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target.

Liliana Raimundo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.